Canada is proceeding with its digital services tax on technology companies such as Meta despite a Group of Seven agreement that resulted in removing the Section 899 “revenge tax” proposal from U.S. President Donald Trump’s tax bill. The first payment for Canada’s digital tax is still due Monday, the country’s Read more…
The UK government has rejected the 25 billion ($34.39 billion) pound Morocco-UK Power Project, citing a preference for domestic renewable initiatives that offer greater economic and strategic benefits. The project aimed to supply solar and wind energy from the Sahara to power up to seven million UK homes. Reuters reports: Read more…
Surgeons have performed the first fully robotic heart transplant in the U.S., using advanced robotic tools to avoid opening the chest. […] Using a surgical robot, lead surgeon Dr. Kenneth Liao and his team made small, precise incisions, eliminating the need to open the chest and break the breast bone. Read more…
Accenture is facing mounting challenges as AI threatens to disrupt the consulting industry the company helped build. The Dublin-based firm, which made its fortune advising clients on adapting to new technologies from the internet to cloud computing, now confronts the same predicament as generative AI reshapes business operations. The company’s Read more…
The head of the federal government agency that oversees Fannie Mae and Freddie Mac wants the mortgage giants to consider accepting a homebuyer’s cryptocurrency holdings in their criteria for buying mortgages from banks. William Pulte, director of the Federal Housing Finance Agency, which oversees Fannie and Freddie, ordered the agencies Read more…
Salesforce chief executive Marc Benioff said Thursday his company has automated a significant chunk of work with AI, another example of a firm touting labor-replacing potential of the emerging technology. “AI is doing 30% to 50% of the work at Salesforce now,” Benioff said in an interview, pointing at job Read more…
A groundbreaking stem cell treatment developed by Vertex Pharmaceuticals has allowed 10 out of 12 patients with severe type 1 diabetes to stop insulin therapy after one year. While the trial included some side effects and two unrelated deaths, the results mark a major step forward and have progressed to Read more…